Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market. Commercialization of non invasive cancer diagnostics and technologies is expected to grow owing to completion of human genome project (HGP) which will help in identifying chemical base pairs which make up DNA, hence opening avenues for market players. Rising awareness amongst people about the advantages of early diagnosis and treatment of cancer has led to a hike in number of people undergoing diagnosis. Furthermore, growing research and development in cancer diagnosis and treatment is another factor that is boosting the growth. Advancements in cancer detection technologies like cancer biomarkers and fluorescence in situ hybridization (FISH) technique are also expected to contribute towards the growth of this market.
The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization
The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type (2019-2025)
1.3.2 CTCs
1.3.3 CTNAS
1.3.4 Exosomes
1.4 Market Segment by Application
1.4.1 Global Non-Invasive Cancer Diagnostics Market Share by Application (2019-2025)
1.4.2 Blood
1.4.3 Urine
1.4.4 Saliva
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Invasive Cancer Diagnostics Market Size
2.1.1 Global Non-Invasive Cancer Diagnostics Revenue 2014-2025
2.1.2 Global Non-Invasive Cancer Diagnostics Sales 2014-2025
2.2 Non-Invasive Cancer Diagnostics Growth Rate by Regions
2.2.1 Global Non-Invasive Cancer Diagnostics Sales by Regions 2014-2019
2.2.2 Global Non-Invasive Cancer Diagnostics Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers
3.1.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers 2014-2019
3.1.2 Non-Invasive Cancer Diagnostics Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Non-Invasive Cancer Diagnostics Revenue by Manufacturers (2014-2019)
3.2.2 Non-Invasive Cancer Diagnostics Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.3 Non-Invasive Cancer Diagnostics Price by Manufacturers
3.4 Key Manufacturers Non-Invasive Cancer Diagnostics Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Non-Invasive Cancer Diagnostics Market
3.6 Key Manufacturers Non-Invasive Cancer Diagnostics Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 CTCs Sales and Revenue (2014-2019)
4.1.2 CTNAS Sales and Revenue (2014-2019)
4.1.3 Exosomes Sales and Revenue (2014-2019)
4.2 Global Non-Invasive Cancer Diagnostics Sales Market Share by Type
4.3 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type
4.4 Non-Invasive Cancer Diagnostics Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Non-Invasive Cancer Diagnostics Sales by Application
6 United States
6.1 United States Non-Invasive Cancer Diagnostics Breakdown Data by Company
6.2 United States Non-Invasive Cancer Diagnostics Breakdown Data by Type
6.3 United States Non-Invasive Cancer Diagnostics Breakdown Data by Application
7 European Union
7.1 European Union Non-Invasive Cancer Diagnostics Breakdown Data by Company
7.2 European Union Non-Invasive Cancer Diagnostics Breakdown Data by Type
7.3 European Union Non-Invasive Cancer Diagnostics Breakdown Data by Application
8 China
8.1 China Non-Invasive Cancer Diagnostics Breakdown Data by Company
8.2 China Non-Invasive Cancer Diagnostics Breakdown Data by Type
8.3 China Non-Invasive Cancer Diagnostics Breakdown Data by Application
9 Rest of World
9.1 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Company
9.2 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Type
9.3 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Application
9.4 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Countries
9.4.1 Rest of World Non-Invasive Cancer Diagnostics Sales by Countries
9.4.2 Rest of World Non-Invasive Cancer Diagnostics Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Gen-Probe Inc
10.1.1 Gen-Probe Inc Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.1.4 Non-Invasive Cancer Diagnostics Product Introduction
10.1.5 Gen-Probe Inc Recent Development
10.2 Digene Corporation
10.2.1 Digene Corporation Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.2.4 Non-Invasive Cancer Diagnostics Product Introduction
10.2.5 Digene Corporation Recent Development
10.3 Quest Diagnostics Inc
10.3.1 Quest Diagnostics Inc Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.3.4 Non-Invasive Cancer Diagnostics Product Introduction
10.3.5 Quest Diagnostics Inc Recent Development
10.4 Cancer, Genetics Inc
10.4.1 Cancer, Genetics Inc Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.4.4 Non-Invasive Cancer Diagnostics Product Introduction
10.4.5 Cancer, Genetics Inc Recent Development
10.5 BIOVIEW Inc
10.5.1 BIOVIEW Inc Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.5.4 Non-Invasive Cancer Diagnostics Product Introduction
10.5.5 BIOVIEW Inc Recent Development
10.6 AVIVA Biosciences Corporation
10.6.1 AVIVA Biosciences Corporation Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.6.4 Non-Invasive Cancer Diagnostics Product Introduction
10.6.5 AVIVA Biosciences Corporation Recent Development
10.7 Laboratory Corporation of America Holdings (LabCorp)
10.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.7.4 Non-Invasive Cancer Diagnostics Product Introduction
10.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Development
10.8 A&G Pharmaceutical
10.8.1 A&G Pharmaceutical Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.8.4 Non-Invasive Cancer Diagnostics Product Introduction
10.8.5 A&G Pharmaceutical Recent Development
10.9 Affymetrix Inc
10.9.1 Affymetrix Inc Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.9.4 Non-Invasive Cancer Diagnostics Product Introduction
10.9.5 Affymetrix Inc Recent Development
10.10 Precision Therapeutics
10.10.1 Precision Therapeutics Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.10.4 Non-Invasive Cancer Diagnostics Product Introduction
10.10.5 Precision Therapeutics Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Non-Invasive Cancer Diagnostics Sales Channels
11.2.2 Non-Invasive Cancer Diagnostics Distributors
11.3 Non-Invasive Cancer Diagnostics Customers
12 Market Forecast
12.1 Global Non-Invasive Cancer Diagnostics Sales and Revenue Forecast 2019-2025
12.2 Global Non-Invasive Cancer Diagnostics Sales Forecast by Type
12.3 Global Non-Invasive Cancer Diagnostics Sales Forecast by Application
12.4 Non-Invasive Cancer Diagnostics Forecast by Regions
12.4.1 Global Non-Invasive Cancer Diagnostics Sales Forecast by Regions 2019-2025
12.4.2 Global Non-Invasive Cancer Diagnostics Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type (2019-2025)
1.3.2 CTCs
1.3.3 CTNAS
1.3.4 Exosomes
1.4 Market Segment by Application
1.4.1 Global Non-Invasive Cancer Diagnostics Market Share by Application (2019-2025)
1.4.2 Blood
1.4.3 Urine
1.4.4 Saliva
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Invasive Cancer Diagnostics Market Size
2.1.1 Global Non-Invasive Cancer Diagnostics Revenue 2014-2025
2.1.2 Global Non-Invasive Cancer Diagnostics Sales 2014-2025
2.2 Non-Invasive Cancer Diagnostics Growth Rate by Regions
2.2.1 Global Non-Invasive Cancer Diagnostics Sales by Regions 2014-2019
2.2.2 Global Non-Invasive Cancer Diagnostics Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers
3.1.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers 2014-2019
3.1.2 Non-Invasive Cancer Diagnostics Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Non-Invasive Cancer Diagnostics Revenue by Manufacturers (2014-2019)
3.2.2 Non-Invasive Cancer Diagnostics Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.3 Non-Invasive Cancer Diagnostics Price by Manufacturers
3.4 Key Manufacturers Non-Invasive Cancer Diagnostics Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Non-Invasive Cancer Diagnostics Market
3.6 Key Manufacturers Non-Invasive Cancer Diagnostics Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 CTCs Sales and Revenue (2014-2019)
4.1.2 CTNAS Sales and Revenue (2014-2019)
4.1.3 Exosomes Sales and Revenue (2014-2019)
4.2 Global Non-Invasive Cancer Diagnostics Sales Market Share by Type
4.3 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type
4.4 Non-Invasive Cancer Diagnostics Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Non-Invasive Cancer Diagnostics Sales by Application
6 United States
6.1 United States Non-Invasive Cancer Diagnostics Breakdown Data by Company
6.2 United States Non-Invasive Cancer Diagnostics Breakdown Data by Type
6.3 United States Non-Invasive Cancer Diagnostics Breakdown Data by Application
7 European Union
7.1 European Union Non-Invasive Cancer Diagnostics Breakdown Data by Company
7.2 European Union Non-Invasive Cancer Diagnostics Breakdown Data by Type
7.3 European Union Non-Invasive Cancer Diagnostics Breakdown Data by Application
8 China
8.1 China Non-Invasive Cancer Diagnostics Breakdown Data by Company
8.2 China Non-Invasive Cancer Diagnostics Breakdown Data by Type
8.3 China Non-Invasive Cancer Diagnostics Breakdown Data by Application
9 Rest of World
9.1 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Company
9.2 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Type
9.3 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Application
9.4 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Countries
9.4.1 Rest of World Non-Invasive Cancer Diagnostics Sales by Countries
9.4.2 Rest of World Non-Invasive Cancer Diagnostics Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Gen-Probe Inc
10.1.1 Gen-Probe Inc Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.1.4 Non-Invasive Cancer Diagnostics Product Introduction
10.1.5 Gen-Probe Inc Recent Development
10.2 Digene Corporation
10.2.1 Digene Corporation Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.2.4 Non-Invasive Cancer Diagnostics Product Introduction
10.2.5 Digene Corporation Recent Development
10.3 Quest Diagnostics Inc
10.3.1 Quest Diagnostics Inc Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.3.4 Non-Invasive Cancer Diagnostics Product Introduction
10.3.5 Quest Diagnostics Inc Recent Development
10.4 Cancer, Genetics Inc
10.4.1 Cancer, Genetics Inc Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.4.4 Non-Invasive Cancer Diagnostics Product Introduction
10.4.5 Cancer, Genetics Inc Recent Development
10.5 BIOVIEW Inc
10.5.1 BIOVIEW Inc Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.5.4 Non-Invasive Cancer Diagnostics Product Introduction
10.5.5 BIOVIEW Inc Recent Development
10.6 AVIVA Biosciences Corporation
10.6.1 AVIVA Biosciences Corporation Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.6.4 Non-Invasive Cancer Diagnostics Product Introduction
10.6.5 AVIVA Biosciences Corporation Recent Development
10.7 Laboratory Corporation of America Holdings (LabCorp)
10.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.7.4 Non-Invasive Cancer Diagnostics Product Introduction
10.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Development
10.8 A&G Pharmaceutical
10.8.1 A&G Pharmaceutical Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.8.4 Non-Invasive Cancer Diagnostics Product Introduction
10.8.5 A&G Pharmaceutical Recent Development
10.9 Affymetrix Inc
10.9.1 Affymetrix Inc Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.9.4 Non-Invasive Cancer Diagnostics Product Introduction
10.9.5 Affymetrix Inc Recent Development
10.10 Precision Therapeutics
10.10.1 Precision Therapeutics Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.10.4 Non-Invasive Cancer Diagnostics Product Introduction
10.10.5 Precision Therapeutics Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Non-Invasive Cancer Diagnostics Sales Channels
11.2.2 Non-Invasive Cancer Diagnostics Distributors
11.3 Non-Invasive Cancer Diagnostics Customers
12 Market Forecast
12.1 Global Non-Invasive Cancer Diagnostics Sales and Revenue Forecast 2019-2025
12.2 Global Non-Invasive Cancer Diagnostics Sales Forecast by Type
12.3 Global Non-Invasive Cancer Diagnostics Sales Forecast by Application
12.4 Non-Invasive Cancer Diagnostics Forecast by Regions
12.4.1 Global Non-Invasive Cancer Diagnostics Sales Forecast by Regions 2019-2025
12.4.2 Global Non-Invasive Cancer Diagnostics Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
